Scopolamine impairs memory performance and reduces frontal but not parietal visual P3 amplitude.
- Authors
- Potter, D D; Pickles, C D; Roberts, R C; Rugg, M D
- Year
- 2000
- Journal
- Biological psychology
- PMID
- 10686371
- DOI
- 10.1016/s0301-0511(99)00023-x
It has been suggested that the P3 event-related potential (ERP) may mark the operation of certain working or long-term memory processes. It has also been reported that cholinergic blockade by scopolamine induces significant memory impairment and is associated with an increased latency, as well as amplitude reduction or abolition of the auditory P3, thus supporting hypothesised links between P3 and long-term memory function. An intriguing anomaly is that, while visual P3 latency is also increased by scopolamine, amplitude is not changed. The aim of this study was to make a more detailed assessment of the effects of scopolamine on the visual P3 at a drug dose known to induce memory impairment. After drug administration, memory performance was significantly impaired and visual P3 latency was significantly increased. There was little evidence of parietal P3 amplitude reduction, but frontal P3 amplitude was significantly reduced in both target and non-target conditions. These findings, when considered in the light of a more recent study of the effects of scopolamine on auditory P3, suggest that cholinergic blockade produces a common effect in both visual and auditory modalities of significant frontal P3 amplitude reduction, but no significant parietal P3 amplitude reduction. These results are consistent with the view that there are modality-independent generators of the parietal and frontal P3. The finding of drug-induced memory impairment and modulations of frontal ERP deflections is also consistent with recent evidence of a significant role for regions of the frontal lobe in encoding and retrieval of long-term memories.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Vitamin B<sub>12</sub>-folic acid supplementation improves memory by altering mitochondrial dynamics, dendritic arborization, and neurodegeneration in old and amnesic male mice. | Mishra E et al. | — | 2024 | → |
| Cholinergic modulation of sensory perception and plasticity. | Kunnath AJ et al. | — | 2023 | → |
| Predictive Power of Cognitive Biomarkers in Neurodegenerative Disease Drug Development: Utility of the P300 Event-Related Potential. | Olichney J et al. | — | 2022 | → |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial. | Hua X et al. | — | 2022 | → |
| Less is more: Deprescribing anticholinergic medications in persons with severe mental illness. | Lupu AM et al. | — | 2021 | → |
| The motor vertical in the absence of gravicentric cues. | Bock O et al. | — | 2020 | → |
| Anticholinergic Amnesia is Mediated by Alterations in Human Network Connectivity Architecture. | Chhatwal JP et al. | — | 2019 | → |
| Identification and pharmacological profile of SPP1, a potent, functionally selective and brain penetrant agonist at muscarinic M<sub>1</sub> receptors. | Broad LM et al. | — | 2019 | → |
| In Vitro Pharmacological Characterization and In Vivo Validation of LSN3172176 a Novel M1 Selective Muscarinic Receptor Agonist Tracer Molecule for Positron Emission Tomography. | Mogg AJ et al. | — | 2018 | → |
| The ameliorating effect of 1-palmitoyl-2-linoleoyl-3-acetylglycerol on scopolamine-induced memory impairment via acetylcholinesterase inhibition and LTP activation. | Jeon SJ et al. | — | 2017 | → |
| Visual Selective Attention Toward Novel Stimuli Predicts Cognitive Decline in Alzheimer's Disease Patients. | Chau SA et al. | — | 2017 | → |
| The ethanolic extract of the Eclipta prostrata L. ameliorates the cognitive impairment in mice induced by scopolamine. | Jung WY et al. | — | 2016 | → |
| Noradrenergic and cholinergic modulation of late ERP responses to deviant stimuli. | Brown SB et al. | — | 2015 | → |
| Brain Network Activation (BNA) reveals scopolamine-induced impairment of visual working memory. | Reches A et al. | — | 2014 | → |
| Understanding alcohol use disorders with neuroelectrophysiology. | Rangaswamy M et al. | — | 2014 | → |
| Ethanolic Extract of the Seed of Zizyphus jujuba var. spinosa Ameliorates Cognitive Impairment Induced by Cholinergic Blockade in Mice. | Lee HE et al. | — | 2013 | → |
| Event-Related Oscillations in Alcoholism Research: A Review. | Pandey AK et al. | — | 2012 | → |
| Event-related potentials for the diagnosis of mild cognitive impairment and Alzheimer's disease. | Kimiskidis VK et al. | — | 2012 | → |
| Effect of oxybutynin and imidafenacin on central muscarinic receptor occupancy and cognitive function: a monkey PET study with [(11)C](+)3-MPB. | Yamamoto S et al. | — | 2011 | → |
| Muscarinic receptor occupancy and cognitive impairment: a PET study with [11C](+)3-MPB and scopolamine in conscious monkeys. | Yamamoto S et al. | — | 2011 | → |
| Novelty enhancements in memory are dependent on lateral prefrontal cortex. | Kishiyama MM et al. | — | 2009 | → |
| From event-related potential to oscillations: genetic diathesis in brain (dys)function and alcohol dependence. | Rangaswamy M et al. | — | 2008 | → |
| Uncovering genes for cognitive (dys)function and predisposition for alcoholism spectrum disorders: a review of human brain oscillations as effective endophenotypes. | Rangaswamy M et al. | — | 2008 | → |
| A cholinergic receptor gene (CHRM2) affects event-related oscillations. | Jones KA et al. | — | 2006 | → |
| Are cholinergic enhancers beneficial for memory in schizophrenia? An event-related potentials (ERPs) study of rivastigmine add-on therapy in a crossover trial. | Guillem F et al. | — | 2006 | → |
| Attention-deficit/hyperactivity disorder: neurophysiology, information processing, arousal and drug development. | Rowe DL et al. | — | 2006 | → |
| Genetics of human brain oscillations. | Begleiter H et al. | — | 2006 | → |
| Age-related cognitive decline in the menopause: effects of hormone replacement therapy on cognitive event-related potentials. | Anderer P et al. | — | 2005 | → |
| The utility of neurophysiological markers in the study of alcoholism. | Porjesz B et al. | — | 2005 | → |
| Linkage and linkage disequilibrium of evoked EEG oscillations with CHRM2 receptor gene polymorphisms: implications for human brain dynamics and cognition. | Jones KA et al. | — | 2004 | → |
| Sparing of perceptual implicit memory despite suppression of the electrophysiological word repetition effect: a study with general anesthetic isoflurane. | Villemure C et al. | — | 2004 | → |
| The genetics of oscillations in the human brain. | Porjesz B et al. | — | 2004 | → |
| Cholinergic modulation of learning and memory in the human brain as detected with functional neuroimaging. | Thiel CM | — | 2003 | → |
| Effects of hormone replacement therapy on perceptual and cognitive event-related potentials in menopausal insomnia. | Anderer P et al. | — | 2003 | → |
| Lorazepam induces an atypical dissociation of visual and auditory event-related potentials. | Pompéia S et al. | — | 2003 | → |
| Neural mechanisms for detecting and remembering novel events. | Ranganath C et al. | — | 2003 | → |
| The nucleus basalis and memory codes: auditory cortical plasticity and the induction of specific, associative behavioral memory. | Weinberger NM | — | 2003 | → |
| Impairment of an event-related potential correlate of memory in schizophrenia: effects of immediate and delayed word repetition. | Matsumoto K et al. | — | 2001 | → |